These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 2993590)

  • 21. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Satoh Y; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal hemodynamics in hemorrhagic hypotension: studies on the effects of pre- and postjunctional dopamine receptor agonists.
    Hamed AT; Ginos JZ; Ekas RD; Jandhyala BS; Lokhandwala MF
    J Cardiovasc Pharmacol; 1983; 5(2):207-12. PubMed ID: 6188891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists.
    Park KH; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
    Nishiyama S; Yoshikawa M; Yamaguchi I
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
    Mercuro G; Rossetti Z; Rivano AC; Tocco L; Ruscazio M; Stefanini E; Gessa GL; Cherchi A
    Cardiologia; 1987 Jul; 32(7):643-50. PubMed ID: 3690588
    [No Abstract]   [Full Text] [Related]  

  • 28. Gastric cytoprotection induced by prostaglandin-dopaminergic mechanism.
    Laudanno OM; Bedini OA; San Miguel P; Cesolari JA
    Acta Gastroenterol Latinoam; 1987; 17(4):299-303. PubMed ID: 2905107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of [3H]dopamine release from rabbit retina.
    Dubocovich ML
    Fed Proc; 1984 Sep; 43(12):2714-8. PubMed ID: 6468669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine: receptors and clinical applications.
    Goldberg LI
    Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.
    Sowinski BA; Lokhandwala MF
    J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Morales-Olivas FJ; Palop V; Rubio E; Esplugues J
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):71-8. PubMed ID: 6151381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
    Salvati P; Bianchi G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390.
    Frederickson ED; Bradley T; Goldberg LI
    Am J Physiol; 1985 Aug; 249(2 Pt 2):F236-40. PubMed ID: 3161340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypotensive effect of dopaminergic agonists in the rat].
    Prieto JC; Quevedo M; Sapunar J; Pérez-Olea J
    Arch Inst Cardiol Mex; 1987; 57(4):279-84. PubMed ID: 2960282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine decreases blood pressure of spontaneously hypertensive rats without affecting the adrenomedullary synthesis of catecholamines.
    Racz K; Kuchel O; Buu NT
    J Cardiovasc Pharmacol; 1986; 8(4):676-80. PubMed ID: 2427803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.